August 22, 2016 / 8:11 PM / a year ago

BRIEF-Lombard Medical reports Q2 loss per share $0.42

Aug 22 (Reuters) - Lombard Medical Inc

* Reports 2016 second quarter, six-month financial results and provides update on strategic initiatives

* Q2 loss per share $0.42

* Q2 revenue $3.8 million versus I/B/E/S view $3.8 million

* Q2 earnings per share view $-0.40 -- Thomson Reuters I/B/E/S

* Board of directors has engaged Cain Brothers as its investment banker to begin a process of exploring strategic alternatives

* Exploring strategic alternatives, including a potential sale of company or disposition of certain assets

* Company will also be evaluating additional financing opportunities

* Allocating resources to support new Altura AAA stent graft system and Intelliflex LP delivery system for Aorfix in European Union, Japan and other international markets

* Due to suspension of US commercial operation, says "prudent" to amend revenue guidance for year to between $13 million and $15 million

* Aorfix sales force in us has been eliminated and majority of commercial operations have transitioned to company's facility in UK Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below